Carvedilol

(R)-Carvedilol ((R)-BM 14190), the R-enantiomer of Carvedilol, is a non-selective β/α-1 blocker. (R)-Carvedilol exerts protection against the vascular or cardiac toxicity of Doxorubicin (DOX)Form:SolidIC50&amp: Target:β/α-1 adrenergic receptor.

(R)-Carvedilol ((R)-BM 14190), the R-enantiomer of Carvedilol, is a non-selective β/α-1 blocker. (R)-Carvedilol exerts protection against the vascular or cardiac toxicity of Doxorubicin (DOX)Form:SolidIC50&amp: Target:β/α-1 adrenergic receptor.

(R)-Carvedilol ((R)-BM 14190), the R-enantiomer of Carvedilol, is a non-selective β/α-1 blocker. (R)-Carvedilol exerts protection against the vascular or cardiac toxicity of Doxorubicin (DOX)Form:SolidIC50&amp: Target:β/α-1 adrenergic receptor.

Carvedilol is an a1- and &szlig1/2-adrenergic receptor antagonist used to treat congestive heart failure its inhibitory action at adrenergic receptors slows heart rhythm, decreasing force, pressure, and cardiac workload. Carvedilol also inhibits

BLOCK HTR DGTL DUAL 130C 120V

BLOCK HTR DGTL DUAL 200C 120V

BLOCK HTR DGTL DUAL 200C 230V

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Application Carvedilol has been used: as a &#946 blocker to determine its effect on hypoxia inducible factor (HIF)-mediated erythropoiesis under hypoxia in vivo as a &#946AR antagonist for inhibition of bARs as a &#946-blocker to examine airway

Application Carvedilol has been used: as a &#946 blocker to determine its effect on hypoxia inducible factor (HIF)-mediated erythropoiesis under hypoxia in vivo as a &#946AR antagonist for inhibition of bARs as a &#946-blocker to examine airway

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the